Compare Eli Lilly And Co (LLY) vs Occidental Petroleum Corporation (OXY) Price & Performance

Eli Lilly (LLY) trades at $1,221.21, down 0.84% today, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The stock shows technical strength with bullish moving averages and support at $1,207, while fundamentals reveal exceptional profitability with 33.53% net margins and 48% revenue growth in Q2 2026. Recent news highlights the company's aggressive protection of its obesity drug pipeline against black market sales.

LLY presents a compelling growth story with dominant market positioning in weight-loss drugs and strong analyst support (73% buy ratings). Key risks include regulatory scrutiny and competitive pressures, but the company's raised guidance and pipeline advancements support continued upside toward the $1,380 consensus target.

Occidental Petroleum (OXY) trades at $58.46, down 0.32% on the day, with a bullish technical outlook and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $2.40, surpassing expectations, and targets over $4 billion in annual sustainable cash flow gains by 2030. Valuation ratios like P/E of 16.49 and EV/EBITDA of 5.26 appear reasonable, while profitability metrics such as ROE of 21.46% highlight operational strength. Recent news emphasizes debt reduction and oil price leverage.

OXY offers upside with a consensus price target of $69.33, supported by analyst buy ratings (50%) and institutional optimism. Key risks include oil price volatility and execution of cash flow targets, but fundamentals and sentiment suggest a favorable outlook for investors seeking energy exposure.